Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dorca

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|April 20, 2001
Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxoneB Rosón, J Carratalà, F Tubau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2014
Impact of pre-hospital antibiotic use on community-acquired pneumoniaA F Simonetti, D Viasus, C Garcia-Vidal, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 1995
Efficacy, safety, and therapeutic relevance of transthoracic aspiration with ultrathin needle in nonventilated nosocomial pneumoniaJ Dorca, F Manresa, L Esteban, et al.
Archivos De Bronconeumologia|May 1, 1997
[The diagnosis and treatment of community-acquired pneumonia. SEPAR. Sociedad Española de Neumología y Cirugía Torácica]J Dorca, S Bello, J Blanquer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 6, 2011
Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalizationC Garcia-Vidal, D Viasus, A Roset, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 30, 2016
Declining mortality among hospitalized patients with community-acquired pneumoniaA F Simonetti, C Garcia-Vidal, D Viasus, et al.
Medicina Clinica|October 5, 1996
[The risk of breast cancer in Catalonia]A Izquierdo, P Viladiu, J Borrás, et al.
The European Respiratory Journal|September 1, 1995
Risk factors for the development of Haemophilus influenzae pneumonia in hospitalized adultsB Barreiro, J Dorca, L Esteban, et al.
The New England Journal of Medicine|July 2, 1987
Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococciR Pallares, F Gudiol, J Liñares, et al.
Thorax|December 10, 2009
Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomesC Garcia-Vidal, C Ardanuy, F Tubau, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Microbial Drug Resistance (Larchmont, N.Y.)|April 20, 2001
Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxoneB Rosón, J Carratalà, F Tubau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2014
Impact of pre-hospital antibiotic use on community-acquired pneumoniaA F Simonetti, D Viasus, C Garcia-Vidal, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 1995
Efficacy, safety, and therapeutic relevance of transthoracic aspiration with ultrathin needle in nonventilated nosocomial pneumoniaJ Dorca, F Manresa, L Esteban, et al.
Archivos De Bronconeumologia|May 1, 1997
[The diagnosis and treatment of community-acquired pneumonia. SEPAR. Sociedad Española de Neumología y Cirugía Torácica]J Dorca, S Bello, J Blanquer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 6, 2011
Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalizationC Garcia-Vidal, D Viasus, A Roset, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 30, 2016
Declining mortality among hospitalized patients with community-acquired pneumoniaA F Simonetti, C Garcia-Vidal, D Viasus, et al.
Medicina Clinica|October 5, 1996
[The risk of breast cancer in Catalonia]A Izquierdo, P Viladiu, J Borrás, et al.
The European Respiratory Journal|September 1, 1995
Risk factors for the development of Haemophilus influenzae pneumonia in hospitalized adultsB Barreiro, J Dorca, L Esteban, et al.
The New England Journal of Medicine|July 2, 1987
Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococciR Pallares, F Gudiol, J Liñares, et al.
Thorax|December 10, 2009
Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomesC Garcia-Vidal, C Ardanuy, F Tubau, et al.
Pageof 7